Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

Author:

Groen Kazimierz12,Schjesvold Fredrik H.34,van der Holt Bronno5,Levin Mark-David6,Seefat Maarten R.12,Hansson Markus7,Leys Maria B.L.8,Regelink Josien C.9,Waage Anders10,Szatkowski Damian11,Axelsson Per12,Hieu Do Trung13,Svirskaite Asta14,van der Spek Ellen15,Haukas Einar16,Knut-Bojanowska Dorota17,Ypma Paula F.18,Blimark Cecilie H.19,Mellqvist Ulf-Henrik20,van de Donk Niels W.C.J.12,Sonneveld Pieter21,Klostergaard Anja22,Vangsted Annette J.23,Abildgaard Niels24,Zweegman Sonja12

Affiliation:

1. Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands

2. Cancer Center Amsterdam, Treatment and Quality of Life, the Netherlands

3. Department of Hematology, Oslo Myeloma Center, Oslo University Hospital, Norway

4. KG Jebsen Center for B Cell Malignancies, University of Oslo, Norway

5. Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

6. Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands

7. Department of Hematology, Skåne University Hospital Lund, Sweden

8. Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands

9. Department of Internal Medicine, Meander Medical Centre, Amersfoort, the Netherlands

10. Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

11. Department of Oncology and Hematology, Førde Central Hospital, Norway

12. Department of Internal Medicine, Helsingborg Hospital, Sweden

13. Haematology Department H 60, Roskilde Sjaelland University, Denmark

14. Department of Hematology, Aalborg University Hospital, Denmark

15. Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands

16. Department for Blood and Cancer Diseases, Stavanger University Hospital, Norway

17. Institute of Heamatology, Uddevalla Hospital, Sweden

18. Department of Hematology, Haga Hospital, The Hague, the Netherlands

19. Hematology Department, Sahlgrenska University Hospital, Gothenburg, Sweden

20. Department of Internal Medicine, Sodra Alvsborgs Sjukhus, Boras, Sweden

21. Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

22. Department of Hematology, Aarhus University Hospital, Denmark

23. Department of Hematology, Rigshospitalet, Copenhagen, Denmark

24. Department of Hematology, Hematology Research Unit and Academy of Geriatric Research, Odense University Hospital and University of Southern Denmark, Denmark

Publisher

Wiley

Subject

Hematology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3